Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RX3 Growth Partners, commonly referred to as Rx3 Ventures, is a private consumer-focused growth equity and venture investment firm rather than a life sciences, biotech, pharma, or healthcare operating company. The firm was co-founded by Aaron Rodgers, Nate Raabe, and Byron Roth and is known for investing in consumer brands using a network of athletes, celebrities, and influencers to support portfolio company growth. Its portfolio has included companies such as Hydrow, Hydrant, Therabody, Super Coffee, Tocaya, and Nom Nom. Based on available public information, RX3 does not appear to develop therapeutic products, run a drug pipeline, or operate as a healthcare R&D company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rx3 Ventures.